Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Cash from Financing Activities (2023 - 2024)

Exozymes (EXOZ) has disclosed Cash from Financing Activities for 2 consecutive years, with $15.4 million as the latest value for Q4 2024.

  • Quarterly Cash from Financing Activities rose 3075.94% to $15.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Dec 2024, changed N/A year-over-year, with the annual reading at -$27709.0 for FY2025, 100.15% down from the prior year.
  • Cash from Financing Activities for Q4 2024 was $15.4 million at Exozymes, up from $586363.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $15.4 million in Q4 2024, with the low at -$91507.0 in Q1 2024.